Edition:
United States

Oncternal Therapeutics Inc (ONCT.PH)

ONCT.PH on Philadelphia Stock Exchange

5.86USD
23 Aug 2019
Change (% chg)

$1.13 (+23.89%)
Prev Close
$4.73
Open
$5.86
Day's High
$5.86
Day's Low
$5.86
Volume
100
Avg. Vol
813
52-wk High
$25.50
52-wk Low
$0.77

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

James Breitmeyer

65 2019 President, Chief Executive Officer

Richard Vincent

56 2019 Chief Financial Officer

Hazel Aker

63 2019 General Counsel

Robert Wills

65 2019 Director

Michael Carter

2006 Independent Director